Endophys Technologies is a pioneering company in the field of hemodynamic data monitoring with its groundbreaking product, PressureSense. The company's slogan "Leading the Digital Revolution in Hemodynamic Data Monitoring with PressureSense" encapsulates its vision to improve safety and outcomes in critical medical interventions. Endophys Technologies is at the forefront of revolutionizing hemodynamic monitoring by providing continuous, real-time, hyper-accurate intra-arterial blood pressure monitoring digitally, faster, and more accurately than legacy analog methods. Based in the United States, the company is dedicated to addressing the critical need for precise and efficient blood pressure management during medical procedures. Although specific details about the founding date, industries, and last investment are not provided, the potential for innovation and impact in the healthcare industry is evident in the company's mission. Endophys Technologies presents an intriguing opportunity for venture capital firms seeking to invest in disruptive technologies that can significantly advance medical interventions and patient care.
There is no investment information
No recent news or press coverage available for Endophys Technologies.